SN PEER ANALYSIS

Smith & Nephew PLC — metric-by-metric comparison with peers and the industry median

SNSmith & Nephew PLC

🇬🇧 UK · LSE · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

SNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	SN	INGN	QSI	QTRX	CVRX	INFU	Ind. Median
P/E	20.56●	—	—	—	—	26.83	27.44
P/B	2.48	0.99	1.00	0.72●	5.07	3.61	2.48
EV/EBITDA	9.88	—	—	—	—	9.01●	15.23
P/S	2.09	0.51●	108.75	1.40	2.50	1.49	2.66

Financial Health
Metric	SN	INGN	QSI	QTRX	CVRX	INFU	Ind. Median
Current Ratio	2.57	3.10	12.60●	3.72	10.20	2.14	3.28
Debt/Equity	62.9%	9.3%	1.8%●	12.5%	204.0%	38.8%	44.7%
NetDebt/EBITDA	1.72	18.07	1.35	0.76	0.28●	0.80	0.82

Profitability
Metric	SN	INGN	QSI	QTRX	CVRX	INFU	Ind. Median
Net Margin	10.1%●	-7.1%	-5,605.9%	-71.9%	-89.1%	5.6%	-5.7%
ROE	12.1%	-13.1%	-46.4%	-34.8%	-107.0%	13.9%●	-8.6%
ROA	6.1%	-8.4%	-42.9%	-27.3%	-45.9%	7.8%●	-6.4%
EBITDA Margin	25.6%●	-1.5%	-4,942.7%	-58.4%	-77.8%	18.2%	5.2%

Growth + Dividend
Metric	SN	INGN	QSI	QTRX	CVRX	INFU	Ind. Median
Rev. Growth	—	3.4%	-46.2%	8.2%	11.7%●	3.5%	7.4%
NI Growth	—	—	—	—	—	148.0%	16.7%
Div. Yield	3.5%	—	—	—	—	—	1.1%
Payout	52.8%	—	—	—	—	—	39.0%

Valuation
Metric	SN	CTEC	HLN	HIK	GSK	Ind. Median
P/E	20.56	34.11	31.28	11.43●	14.08	27.44
P/B	2.48	3.94	1.98	1.78●	4.60	2.48
EV/EBITDA	9.88	11.98	19.15	8.74	8.45●	15.23
P/S	2.09	2.45	3.94	1.37●	2.50	2.66

Financial Health
Metric	SN	CTEC	HLN	HIK	GSK	Ind. Median
Current Ratio	2.57●	1.53	0.92	1.82	0.79	3.28
Debt/Equity	62.9%	100.0%	52.3%●	61.8%	106.7%	44.7%
NetDebt/EBITDA	1.72	2.33	3.50	1.87	1.35●	0.82

Profitability
Metric	SN	CTEC	HLN	HIK	GSK	Ind. Median
Net Margin	10.1%	7.2%	12.6%	12.0%	17.8%●	-5.7%
ROE	12.1%	10.9%	6.3%	16.4%	36.4%●	-8.6%
ROA	6.1%	4.8%	3.2%	7.5%	9.4%●	-6.4%
EBITDA Margin	25.6%	25.3%	25.2%	20.0%	35.3%●	5.2%

Growth + Dividend
Metric	SN	CTEC	HLN	HIK	GSK	Ind. Median
Rev. Growth	—	6.8%	-26.7%	7.4%●	4.0%	7.4%
NI Growth	—	-8.0%	-14.2%	12.2%	84.9%●	16.7%
Div. Yield	3.5%	3.3%	2.0%	5.4%●	3.3%	1.1%
Payout	52.8%	78.1%	40.0%	45.2%	44.5%	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.